Dirk Kersten - 26 May 2021 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Director, 10%+ Owner
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol
DYN
Transactions as of
26 May 2021
Transactions value $
$0
Form type
4
Filing time
27 May 2021, 20:38:58 UTC
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock Option (right to buy) Award $0 +19.6K $0.00 19.6K 26 May 2021 Common Stock 19.6K $19.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 26, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 26, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders